These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1699752)

  • 1. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
    Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
    Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
    Johnson TL; Lloyd RV; Thor A
    Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in patients with chronic renal failure.
    Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
    Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical demonstration of thyroglobulin in thyroid pathology.
    Stefăneanu L; Simionescu L; Aman E; Taşcă C
    Endocrinologie; 1984; 22(1):55-9. PubMed ID: 6369503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
    Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
    Odagiri E; Jibiki K; Takeda M; Sugimura H; Iwachika C; Abe Y; Kihara K; Kihara Y; Itou M; Nomura T
    Am J Nephrol; 1991; 11(5):363-8. PubMed ID: 1725572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C cell carcinoma of the thyroid. Follicular variant.
    Lertprasertsuke N; Kakudo K; Nakamura A; Tada N; Osamura Y; Watanabe K; Kubota M
    Acta Pathol Jpn; 1989 Jun; 39(6):393-9. PubMed ID: 2481937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers in chronic renal failure and hemodialysis patients.
    Cases A; Filella X; Molina R; Ballesta AM; Lopez-Pedret J; Revert L
    Nephron; 1991; 57(2):183-6. PubMed ID: 2020345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and tissue levels of CEA, TPA, CA 125 and CA 15.3 in patients with lung cancer.
    Macchia V; Paduano D; Di Carlo A; Mariano A; Cecere C; Ferrante G
    Int J Biol Markers; 1993; 8(4):215-20. PubMed ID: 8138661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA 19-9 expression in subacute (de Quervain's) thyroiditis: an immunohistochemical study.
    Schmid KW; Ofner C; Ramsauer T; Hittmair A; Tötsch M; Ladurner D; Böcker W
    Mod Pathol; 1992 May; 5(3):268-72. PubMed ID: 1495932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
    Unger P; Ewart M; Wang BY; Gan L; Kohtz DS; Burstein DE
    Hum Pathol; 2003 Aug; 34(8):764-9. PubMed ID: 14506636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
    Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
    Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
    Branet F; Caron P; Camallières M; Selves J; Brousset P
    Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
    Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
    Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
    Hocevar M; Auersperg M
    Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.